Inhibition of murine allergic airway disease by Bordetella pertussis

Immunology

Volumn 112, Issue 4, 2004, Pages 624-630

  Kim, Young Suk ^a   Kwon, Keun Sang ^a   Kim, Dae Ki ^a   Choi, Il Whan ^a   Lee, Hern Ku ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

Allergy; Animal models; Th cell response; Vaccines

Indexed keywords

DEOXYRIBONUCLEASE I; DNA; INTERLEUKIN 4; INTERLEUKIN 5; METHACHOLINE; METHYLTRANSFERASE; PERTUSSIS VACCINE;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORDETELLA PERTUSSIS; CHROMOSOME; CONTROLLED STUDY; EOSINOPHIL; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN MOTIF;

ANIMALS; ASTHMA; BORDETELLA PERTUSSIS; BRONCHOCONSTRICTOR AGENTS; DNA, BACTERIAL; DOWN-REGULATION; MALE; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; OVALBUMIN; PERTUSSIS VACCINE; PULMONARY EOSINOPHILIA; RESPIRATORY HYPERSENSITIVITY; TH1 CELLS; TH2 CELLS;

EID: 4043147779     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01880.x     Document Type: Article

References (30)

1. Renz H, Bradley K, Saloga J, Loader J, Larsen GL, Gelfand EW. T cells expressing specific Vβ elements regulate immunoglobulin E production and airways responsiveness in vivo. J Exp Med 1993; 177:1175-80.
2. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17:255-81.
3. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13:501-7.
4. Punnonen J, Aversa G, Cocks BG, de Vries JE. Role of interleukin-4 and interleukin-13 in synthesis of IgE and expression of CD23 by human B cells. Allergy 1994; 49:576-86.
5. Saito H, Hatake K, Dvorak AM, Leiferman KM, Donnenberg AD, Arai N, Ishizaka K, Ishizaka T. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci U S A 1998; 85:2288-92.
6. + T cells. J Exp Med 1993; 177:573-6.
7. Sur S, Lam J, Bouchard P, Sigounas A, Holbert D, Metzger WJ. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses. J Immunol 1996; 157:4173-80.
8. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546-9.
9. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon-γ. Proc Natl Acad Sci U S A 1996; 93:2879-83.
10. Kline JN, Waldschmidt TJ, Businga TR, Lemish JE, Weinstock JV, Thorne PS, Krieg AM. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998; 160:2555-9.
11. Sur S, Wild JS, Choudhury BK, Sur N, Alam R, Klinman DM. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J Immunol 1999; 162:6284-93.
12. Shirota H, Sano K, Kikuchi T, Tamura G, Shirato K. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator. J Immunol 2000; 164:5575-82.
13. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KH. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 1997; 175:1246-50.
14. Ryan M, Murphy G, Ryan E et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 1998; 93:1-10.
15. Redhead K, Watkins J, Barnard A, Mills KH. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun 1993; 61:3190-8.
16. Mills KH, Barnard A, Watkins J, Redhead K. Cell-mediated immunity to Bordetella pertussis, role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun 1993; 61:399-410.
17. Mahon BP, Ryan MS, Griffin F, Mills KH. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun 1996; 64:5295-301.
18. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997; 156:766-75.
19. Horner AA, Van Uden JH, Zubeldia JM, Broide D, Raz E. DNA-based immunotherapeutics for the treatment of allergic disease. Immunol Rev 2001; 179:102-18.
20. Verthelyi D, Klinman DM. Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates. Clin Immunol 2003; 109:64-71.
21. Kline JN, Krieg AM, Waldschmidt YJ, Ballas JK, Jain V, Businga TR. CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma. J Allergy Clin Immunol 1999; 104:1258-64.
22. Sano K, Haneda K, Tamura G, Shirato K. Ovalbumin (OVA) and Mycobacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper (Th) cells toward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia. Am J Respir Cell Mol Biol 1999; 20:1260-7.
23. + T cells and IL-18. J Immunol 2000; 164:223-30.
24. Shirakawa T, Enomoto T, Shimazu SL, Hopkins JM. The inverse association between tuberculin responses and atopic disorders. Science 1997; 275:77-9.
25. von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein O, Bjorksten B, Weiland S. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 2000; 55:449-53.
26. Nahori MA, Lagranderie M, Lefort J et al. Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine 2001; 19:1484-95.
27. Tukenmez F, Bahceciler NN, Barlan IB, Basaran MM. Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin sensitized newborn mice. Pediatr Allergy Immunol 1999; 10:107-11.
28. Horner AA, Raz E. Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: two unique but complementary strategies for the treatment of allergic diseases. J Allergy Clin Immunol 2002; 110:706-12.
29. Underbill DM, Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 2002; 14:103-10.
30. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5.